Literature DB >> 23935546

Protease inhibitor therapy post-liver transplantation in the treatment of hepatitis C virus infection.

Satheesh P Nair1.   

Abstract

Entities:  

Year:  2013        PMID： 23935546      PMCID： PMC3736796     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  2 in total

Review 1.  Host genomics and HCV treatment response.

Authors:  Paul J Clark; Alexander J Thompson
Journal:  J Gastroenterol Hepatol       Date:  2012-02       Impact factor: 4.029

Review 2.  Management of the transplant recipient with chronic hepatitis C.

Authors:  James R Burton; Gregory T Everson
Journal:  Clin Liver Dis       Date:  2013-02       Impact factor: 6.126
  2 in total
  3 in total

Review 1.  Drug-drug interactions with oral anti-HCV agents and idiosyncratic hepatotoxicity in the liver transplant setting.

Authors:  Sarah Tischer; Robert J Fontana
Journal:  J Hepatol       Date:  2013-11-23       Impact factor: 25.083

2.  Tolerability and effectiveness of sofosbuvir and simeprevir in the post-transplant setting: systematic review and meta-analysis.

Authors:  Nghia H Nguyen; Brittany E Yee; Christine Chang; Minjuan Jin; Glen Lutchman; Joseph K Lim; Mindie H Nguyen
Journal:  BMJ Open Gastroenterol       Date:  2016-01-04

Review 3.  Direct-acting antiviral agent efficacy and safety in renal transplant recipients with chronic hepatitis C virus infection: A PRISMA-compliant study.

Authors:  Keliang Chen; Pei Lu; Rijin Song; Jiexiu Zhang; Rongzhen Tao; Zijie Wang; Wei Zhang; Min Gu
Journal:  Medicine (Baltimore)       Date:  2017-07       Impact factor: 1.889
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.